JPM26: Leo Pharma’s growth strategy puts a spotlight on rare dermatology diseases

Advancements in the form of recent approvals and an evolving pipeline landscape in dermatology will bolster Leo’s chance of ...

Kymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs

KT-621 BROADEN2 Phase 2b trial in AD ongoing, with data expected by mid-2027KT-621 BREADTH Phase 2b trial in asthma initiated, with data expected ...
The New York Times

The Best Korean Skin-Care Products

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Rory Evans Rory Evans keeps a small stick of Korean sunscreen in every bag and ...